West Pharmaceutical Services EBITDA Margin 2010-2024 | WST

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for West Pharmaceutical Services (WST) over the last 10 years. The current EBITDA margin for West Pharmaceutical Services as of March 31, 2024 is .
West Pharmaceutical Services EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-03-31 $2.93B $0.79B 26.81%
2023-12-31 $2.95B $0.81B 27.59%
2023-09-30 $2.93B $0.78B 26.58%
2023-06-30 $2.87B $0.78B 27.24%
2023-03-31 $2.88B $0.82B 28.54%
2022-12-31 $2.89B $0.86B 29.62%
2022-09-30 $2.91B $0.91B 31.35%
2022-06-30 $2.93B $0.91B 30.97%
2022-03-31 $2.88B $0.89B 30.81%
2021-12-31 $2.83B $0.87B 30.85%
2021-09-30 $2.68B $0.80B 29.87%
2021-06-30 $2.52B $0.72B 28.46%
2021-03-31 $2.33B $0.61B 26.14%
2020-12-31 $2.15B $0.52B 24.08%
2020-09-30 $2.04B $0.48B 23.36%
2020-06-30 $1.95B $0.44B 22.66%
2020-03-31 $1.89B $0.42B 22.13%
2019-12-31 $1.84B $0.40B 21.73%
2019-09-30 $1.79B $0.39B 21.65%
2019-06-30 $1.77B $0.38B 21.61%
2019-03-31 $1.75B $0.36B 20.68%
2018-12-31 $1.72B $0.35B 20.08%
2018-09-30 $1.71B $0.34B 19.74%
2018-06-30 $1.68B $0.34B 20.20%
2018-03-31 $1.63B $0.32B 19.59%
2017-12-31 $1.60B $0.32B 20.19%
2017-09-30 $1.57B $0.31B 19.99%
2017-06-30 $1.55B $0.30B 19.35%
2017-03-31 $1.54B $0.32B 20.65%
2016-12-31 $1.51B $0.29B 18.89%
2016-09-30 $1.49B $0.28B 18.76%
2016-06-30 $1.46B $0.22B 15.40%
2016-03-31 $1.43B $0.20B 14.09%
2015-12-31 $1.40B $0.22B 15.63%
2015-09-30 $1.39B $0.22B 15.60%
2015-06-30 $1.40B $0.27B 18.90%
2015-03-31 $1.41B $0.28B 19.91%
2014-12-31 $1.42B $0.27B 19.13%
2014-09-30 $1.42B $0.26B 18.66%
2014-06-30 $1.40B $0.26B 18.49%
2014-03-31 $1.38B $0.25B 17.79%
2013-12-31 $1.37B $0.25B 18.12%
2013-09-30 $1.35B $0.24B 17.88%
2013-06-30 $1.31B $0.23B 17.18%
2013-03-31 $1.29B $0.22B 16.74%
2012-12-31 $1.27B $0.21B 16.73%
2012-09-30 $1.24B $0.21B 16.53%
2012-06-30 $1.23B $0.20B 16.59%
2012-03-31 $1.21B $0.20B 16.24%
2011-12-31 $1.19B $0.19B 15.52%
2011-09-30 $1.17B $0.17B 14.05%
2011-06-30 $1.15B $0.16B 14.25%
2011-03-31 $1.13B $0.17B 14.67%
2010-12-31 $1.11B $0.16B 14.84%
2010-09-30 $1.12B $0.18B 15.97%
2010-06-30 $1.11B $0.18B 16.14%
2010-03-31 $1.09B $0.18B 16.18%
2009-12-31 $1.06B $0.17B 15.64%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.159B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00